GlucoTrack
GCTK
4 hedge funds and large institutions have $69.8K invested in GlucoTrack in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 6 closing their positions.
0.06% more ownership
Funds ownership: 0% → 0.06% (+0.06%)
32% less capital invested
Capital invested by funds: $103K → $69.8K (-$32.8K)
50% less funds holding
Funds holding: 8 → 4 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AF
Alerus Financial
Grand Forks,
North Dakota
|
+$335K |
| 2 |
VF
Virtu Financial
New York
|
+$57.3K |
| 3 |
HF
HRT Financial
New York
|
+$39.4K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$42.1K |
| 2 |
Renaissance Technologies
New York
|
-$8.96K |
| 3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$7.46K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$6.13K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$403 |
GCTK Hedge Fund Activity: Q1 2025 in Review
4 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q1 2025, worth a combined $69.8K — down 32% from $103K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of GCTK and 2 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Alerus Financial, adding an estimated $335K. The largest seller was Geode Capital Management, exiting entirely with an estimated $42.1K sold.
- 4 institutional investors held GlucoTrack (GCTK) as of Q1 2025, down from 8 in Q4 2024.
- Funds reported $69.8K of GlucoTrack stock for Q1 2025, down 32% quarter-over-quarter.
- 2 funds opened new GlucoTrack positions in Q1 2025 and 6 closed out, a net change of -4 holders.
- The largest GlucoTrack buyer in Q1 2025 was Alerus Financial, an estimated $335K added.
- The largest GlucoTrack seller in Q1 2025 was Geode Capital Management, an estimated $42.1K sold.
Based on aggregated 13F filings for Q1 2025.